Cargando…
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond
In oncology, prognostic markers are clinical measures used to help elicit an individual patient's risk of a future outcome, such as recurrence of disease after primary treatment. They thus facilitate individual treatment choice and aid in patient counselling. Evidence-based results regarding pr...
Autores principales: | Riley, R D, Sauerbrei, W, Altman, D G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676559/ https://www.ncbi.nlm.nih.gov/pubmed/19367280 http://dx.doi.org/10.1038/sj.bjc.6604999 |
Ejemplares similares
-
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines
por: Burton, A, et al.
Publicado: (2004) -
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
por: Mallett, S, et al.
Publicado: (2010) -
Tumor budding as a potential prognostic marker in determining the behavior of primary liver cancers
por: Unal, Betul, et al.
Publicado: (2023) -
The genomic evolution of human prostate cancer
por: Mitchell, T, et al.
Publicado: (2015) -
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
por: Marisi, Giorgia, et al.
Publicado: (2018)